Testicular cancer is the most common malignancy inÂ men aged 15 to 45 years and represents one of the most common curable malignancies when identified promptly and treated with a multimodal approach. It represents 1% of male tumors and 5% of urological malignancies.

With effective management, the prognosis is excellent with >90% cure rate and >95% five-year survival rate.